For example, it has been shown that PHLPP is downregulated in colon cancer patients and decreased PHLPP expression promotes tumor growth as the result of increased activation of both PI3K/Akt and RAS/RAF oncogenic signaling [12, 13, 15]. This evidence concerns the gene AKT1 and neoplasm.